Fasting Insulin and HOMA-IR: The Biomarkers That Catch Metabolic Disease Decades Early
By the time fasting glucose turns abnormal, insulin resistance and strain on the pancreas have usually been building for years. Fasting insulin and HOMA-IR can reveal that dysfunction earlier than glucose alone.
- Insulin resistance is the root cause of type 2 diabetes, metabolic syndrome, and a primary driver of cardiovascular disease, certain cancers, and Alzheimer's disease. Fasting insulin is the most sensitive available biomarker for detecting insulin resistance before any other standard marker becomes abnormal.
- HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated from fasting insulin and fasting glucose and provides a composite measure of insulin resistance. Higher values mean more insulin resistance, but there is no universal cut-off: thresholds vary with age, sex, population and insulin assay, so track your own trend.
- Fasting insulin reference ranges vary by lab and are based on population norms. Lower values within the range generally reflect better insulin sensitivity, but no "optimal" target has been validated against long-term outcomes.
- A fasting insulin that is elevated but with a normal fasting glucose is the classic picture of compensated insulin resistance - the pancreas is working overtime to maintain normal glucose. This is the critical window for intervention before beta cell exhaustion leads to overt diabetes.
- The most effective interventions for lowering fasting insulin are: reducing refined carbohydrate and sugar intake, increasing aerobic exercise (particularly Zone 2 training), time-restricted eating, achieving and maintaining a healthy body weight, and improving sleep quality.
The global type 2 diabetes epidemic has a silent prelude that lasts decades. Insulin resistance - the reduced ability of cells to respond to insulin's signal to take up glucose - typically develops in the third or fourth decade of life in people who will eventually progress to type 2 diabetes. It is driven by the accumulation of ectopic lipid in insulin-sensitive tissues (liver, muscle, and pancreatic beta cells), chronic low-grade inflammation, visceral adiposity, and physical inactivity. For most of this time, fasting glucose and HbA1c appear completely normal, because the pancreas compensates by secreting ever-increasing amounts of insulin.1
The consequence of measuring only glucose: in the Whitehall II study, insulin sensitivity fell steeply over the five years before diabetes was diagnosed, and the pancreas first raised its insulin output to compensate and then faltered, while fasting glucose rose sharply only in the last three years.6 Measuring fasting insulin can catch the dysfunction at the compensatory stage, when the pancreas is still keeping glucose normal but working harder than it should.
What Fasting Insulin Tells You
In a metabolically healthy, insulin-sensitive individual, the pancreas secretes relatively small amounts of insulin to maintain normal glucose disposal - fasting insulin typically runs between 2 and 6 uIU/mL in genuinely insulin-sensitive people. As insulin resistance develops, the pancreas must secrete progressively more insulin to achieve the same glucose disposal effect. Fasting insulin rises while fasting glucose remains normal - the defining characteristic of compensated insulin resistance.2
Fasting insulin reference ranges (often up to about 20 to 25 uIU/mL) come from population norms rather than outcome studies, and they vary by lab and assay. Lower values within the range generally mean better insulin sensitivity, but no "optimal" target has been validated against long-term outcomes.
HOMA-IR: The Composite Measure
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) was developed by Matthews et al. in 1985 as a mathematical model estimating insulin resistance from fasting insulin and fasting glucose. The formula is: HOMA-IR = (fasting insulin in uIU/mL x fasting glucose in mg/dL) divided by 405. It combines information from both measures, accounting for the fact that glucose and insulin are jointly regulated and that their relationship reflects the degree of insulin resistance more accurately than either alone.3
Interpreting Your Numbers
There is no validated "optimal" fasting insulin or HOMA-IR. In a large general-population study, the HOMA-IR values that flagged insulin resistance differed by age and sex,7 and labs use different insulin assays. The most useful reading is your own trend over time, interpreted alongside glucose, HbA1c, triglycerides and waist size.
Why Insulin Resistance Matters Beyond Diabetes
Insulin resistance is not merely a precursor to diabetes - it is a systemic metabolic disorder with consequences across every major organ system. Cardiovascular disease: insulin resistance drives the atherogenic dyslipidemia (high triglycerides, low HDL, small dense LDL, elevated ApoB), hypertension, and endothelial dysfunction that constitute the metabolic cardiovascular risk cluster. Cancer: insulin and IGF-1 are mitogenic - they promote cell proliferation and inhibit apoptosis. Chronically elevated insulin creates a hormonal environment that promotes tumor growth and is associated with elevated risk of colorectal, breast, endometrial, and pancreatic cancers. Alzheimer's disease: the brain is an insulin-sensitive organ, and insulin signaling is essential for synaptic plasticity, neuronal survival, and amyloid clearance. The term type 3 diabetes has been proposed for cases of Alzheimer's disease driven by brain insulin resistance.4
How to Lower Fasting Insulin
Reduce refined carbohydrate and added sugar intake - the primary dietary drivers of postprandial insulin hypersecretion and progressive beta cell exhaustion. Replacing ultra-processed carbohydrates with whole foods, protein, and fat reliably reduces fasting insulin in insulin-resistant individuals within weeks.5 Zone 2 aerobic exercise is the most potent non-dietary intervention - it directly increases GLUT4 transporter density in muscle cells, improving insulin-independent glucose disposal and significantly reducing the insulin required for glucose homeostasis. Regular aerobic and resistance exercise both improve insulin sensitivity. Time-restricted eating reduces insulin exposure by concentrating the eating window and extending the overnight fasting period during which insulin is at its lowest. Sleep optimization is underappreciated: even one night of partial sleep deprivation (4 hours) produces insulin resistance equivalent to 6 months of a high-fat diet in controlled studies.
Put this research into practice: Biomarker Reference Tool · Lab Results Interpreter
References
- 1Tabák AG, et al. "Prediabetes: a high-risk state for diabetes development." Lancet. 2012;379(9833):2279-90. PubMed · DOI
- 2Reaven GM. "Banting lecture 1988. Role of insulin resistance in human disease." Diabetes. 1988;37(12):1595-607. PubMed · DOI
- 3Matthews DR, et al. "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man." Diabetologia. 1985;28(7):412-9. PubMed · DOI
- 4De Felice FG, Ferreira ST. "Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease." Diabetes. 2014;63(7):2262-72. PubMed · DOI
- 5Volek JS, Phinney SD. "The Art and Science of Low Carbohydrate Living." Beyond Obesity LLC. 2011.
- 6Tabák AG, et al. "Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study." Lancet. 2009;373(9682):2215-21. PubMed · DOI
- 7Gayoso-Diz P, et al. "Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study." BMC Endocr Disord. 2013;13:47. PubMed · DOI